Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MYND Life Sciences Inc
C.MYND
Alternate Symbol(s):
MYNDF
Healthcare
Biotechnology
MYND Life Sciences Inc. is Canada-based medical biotech drug research and development company. The Company is focused on neuro-pharmaceutical and novel psilocybin drug development, and diagnostics. The Company is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by molecular concepts for the applications...
of Psilocybins for overcoming disease. The Company is engaged in pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (CSE:MYND)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(4)
•••
wealth100
X
Post by
wealth100
on Nov 23, 2024 12:52pm
News
Somethng may be brewing...
(4)
•••
AVandelay
X
Post by
AVandelay
on Sep 11, 2023 6:43pm
MYND Announces Update on Debenture Payment Obligations
VANCOUVER, BRITISH COLUMBIA, September 11, 2023 – MYND Life Sciences Inc. (CSE:MYND)(OTC:MYNDF) (“MYND” or the “Company”) today announces it has not made its payment obligations under its
...more
(4)
•••
wealth100
X
Comment by
wealth100
on Apr 07, 2023 1:57pm
RE:MYND Life Sciences Inc. Achieves a Major Milestone
Under the radar...maybe
(4)
•••
AVandelay
X
Post by
AVandelay
on Mar 15, 2023 11:54am
MYND Life Sciences Inc. Achieves a Major Milestone
This seems like a major development, but not much reaction in the stock ... ------------------------ Identification of a potent, monomolecular non-hallucinogenic analog of psilocybin 100 times
...more
(24)
•••
BMcCutcheon
X
Post by
BMcCutcheon
on Jun 17, 2022 5:36pm
MYND Life Sciences celebrates Dr. Wilf Jefferies milestone
MYND Life Sciences celebrates Dr. Wilf Jefferies induction as a National Academy of Inventors Fellow
(188)
•••
TrevorAbes
X
Post by
TrevorAbes
on Jun 01, 2022 5:04pm
MYND announces innovation in psilocybin dosing
https://themarketherald.ca/mynd-life-sciences-announces-new-testing-methodologies-for-measuring-cellular-responses-to-microdosing-with-psilocybins-2022-06-01/
(42)
•••
jballem
X
Post by
jballem
on Apr 27, 2022 3:36pm
MYND Life Sciences announces private placement
https://themarketherald.ca/mynd-life-sciences-announces-3-5-million-share-offering-2022-04-22/
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Oct 13, 2021 7:43pm
Participation in a Monash University (Australia) Proposal
Evaluating the efficacy of psilocybin-assisted psychotherapy in treatment resistant depression VANCOUVER, BC, Oct. 13, 2021 /CNW/ - MYND Diagnostics Inc., a wholly-owned
...more
(8)
•••
Brice978
X
Post by
Brice978
on Sep 17, 2021 10:50am
Big potential in Pyschedelic Names $MYND $CBDX $LVT
Big potential in Pyschedelic Names $MYND $CBDX $LVT https://www.bbc.com/future/article/20210906-what-if-everyone-took-psychedelics
(15)
•••
BayStRising
X
Post by
BayStRising
on Sep 14, 2021 1:59pm
Report on Adastra
https://guerillastocks.com/myndf?utm_campaign=ryan&utm_content=9-13-21 Thoughts? Never heard of this website before.
(8)
•••
Brice978
X
Post by
Brice978
on Sep 14, 2021 11:44am
MYND Life Sciences #Repost #news
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offering $MYND https://finance.yahoo.com/news/mynd-life-sciences-announces-closing-110000616.html
(8)
•••
Brice978
X
Post by
Brice978
on Sep 13, 2021 8:40am
$MYND
$MYND, these guys out of all thepyshceldic companies running clinical trials have some of the best chances for near term revenue with their biomarker.
(14)
•••
SmallCapIntel
X
Post by
SmallCapIntel
on Aug 26, 2021 8:11am
About to be Cashed Up and ready to go!
Nice to see this after several weeks of almost no action on this stock. This now gives them the money to continue their research but also inject some new life into market. What they're working on
...more
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Aug 11, 2021 6:50am
DTC Eligibility
VANCOUVER, BC, Aug. 11, 2021 /PRNewswire/ - MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) ("MYND") is a drug research and development company focused on
...more
(14)
•••
SmallCapIntel
X
Post by
SmallCapIntel
on Jul 26, 2021 8:17am
The trials these guys are working on are amazing
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine